The medicines that rescue children from cancer carry a quieter consequence: they age the body's healthy cells from within, compressing decades of genetic wear into the brief, brutal window of treatment. Researchers in Gothenburg have now mapped this hidden damage with unprecedented precision, revealing that platinum-based chemotherapy leaves tissue-specific wounds in the liver that were previously unknown to science. The discovery does not indict these life-saving drugs, but it deepens our understanding of why so many survivors carry elevated health risks long after their cancer is gone — and
Chemotherapy causes premature genetic aging in children's healthy cells
Childhood cancer survivors face increased risk of secondary cancers, liver disease, and other health complications later in life due to chemotherapy-induced DNA damage.
Decades of genetic wear compressed into months of treatment
Mark
So chemotherapy damages healthy cells too, not just cancer cells? I thought it was supposed to target tumors specifically.
Mimi
It does target tumors, but chemotherapy works by breaking DNA. The problem is it can't tell the difference between a cancer cell and a healthy cell sitting nearby. The drugs kill cancer cells, but they also wound the healthy ones that survive.
Luke
But we've known for decades that chemotherapy has side effects. What's new here?
Mimi
The sensitivity. Previous methods couldn't detect DNA changes in individual cells. This new sequencing technique is ultrasensitive—it can see damage that older methods would have missed entirely.
Mark
And what did they find that's different?
Mimi
Two main things. First, healthy cells age genetically at an accelerated rate—decades of normal damage compressed into months. Second, they found a completely new pattern of DNA damage specific to the liver that no one had identified before.
Luke
Specific to the liver? Why only there?
Mimi
Because that's where the chemotherapy breaks down. The liver metabolizes these drugs, so it gets exposed to them in a particular way. Different tissues experience different kinds of genetic injury from the same drug.
Mark
Does this mean more childhood cancer survivors will get secondary cancers?
Luke
That's the question the study can't fully answer. They found cancer-driving mutations in healthy cells, but they note that only a small proportion of survivors actually develop secondary cancers. So the genetic damage is there, but it doesn't always lead to disease.
Mimi
Right. It's a risk factor, not a guarantee. But it does help explain why survivors have elevated risks compared to the general population.
Mark
So what happens next? Do we stop using these drugs?
Mimi
No. Platinum-based chemotherapy is still the best option for many childhood cancers. There aren't better alternatives yet. The point is to understand the damage so we can develop ways to protect against it.
Le Pouls
- Children cured of cancer are quietly inheriting a second burden: their healthy cells age genetically by decades during months of chemotherapy, a compression of biological time that science is only now beginning to measure.
- A newly identified pattern of DNA damage found exclusively in liver tissue suggests that platinum-based drugs inflict injuries that are not uniform across the body — upending assumptions that have guided oncology for years.
- The stakes are concrete: childhood cancer survivors face elevated risks of secondary cancers, liver disease, and compounding health complications that can shadow them well into adulthood.
- Using an ultrasensitive sequencing technique called NanoSeq, researchers analyzed 186 tissue samples from treated children, producing the clearest picture yet of how chemotherapy rewrites the genetic landscape of healthy cells.
- Scientists are not calling for these drugs to be abandoned — effective alternatives do not yet exist — but the findings now provide a biological map from which protective treatments might be designed.
The medicines that rescue children from cancer carry a quieter consequence: they age the body's healthy cells from within, compressing decades of genetic wear into the brief, brutal window of treatment. Researchers in Gothenburg have now mapped this hidden damage with unprecedented precision, revealing that platinum-based chemotherapy leaves tissue-specific wounds in the liver that were previously unknown to science. The discovery does not indict these life-saving drugs, but it deepens our understanding of why so many survivors carry elevated health risks long after their cancer is gone — and it opens a path toward protecting the body while still defeating the disease.
The drugs that save children from cancer leave something behind. A research team led by Anna Wenger at the Sahlgrenska Center for Cancer Research in Gothenburg, Sweden, has discovered that platinum-based chemotherapy — among the most widely used treatments in childhood oncology — causes healthy cells to accumulate DNA damage equivalent to what a middle-aged adult accrues over decades, compressed into the months of a single treatment course. The findings, published in Science, may finally explain why so many survivors face elevated risks of secondary cancers and liver disease long after their original illness is gone.
The team used an ultrasensitive sequencing method called NanoSeq to examine 186 tissue samples from children who had received chemotherapy, including blood, healthy liver tissue, and liver tumors, alongside control samples from untreated children. The contrast was unambiguous: platinum-treated children showed significantly higher rates of DNA alteration across multiple tissue types, including mutations known to drive cancer — though only a small fraction of survivors will ever develop secondary malignancies.
The most unexpected finding was a pattern of DNA damage found only in the liver, seen in no other tissue examined. Because the liver is responsible for metabolizing platinum-based drugs, researchers believe the organ sustains a localized genetic injury as it breaks down the medication — a discovery that challenges the long-held assumption that chemotherapy produces the same genetic effects throughout the body.
Wenger was careful to frame the research not as an indictment of chemotherapy but as a call for deeper understanding. No equally effective alternatives currently exist, and the goal is not to abandon these drugs but to learn how to protect the body while they do their work. By charting precisely how platinum compounds alter healthy tissue, scientists now have a foundation from which to develop strategies that preserve the life-saving power of chemotherapy while reducing the long-term burden its survivors must carry.
The drugs that save children's lives from cancer leave a hidden wound. Chemotherapy destroys tumor cells by shattering their DNA, but researchers have now discovered it does something else too—it ages the genetic material in healthy cells at an accelerated pace, compressing decades of normal wear into months of treatment.
A team led by Anna Wenger at the Sahlgrenska Center for Cancer Research in Gothenburg, Sweden, used a new ultrasensitive sequencing technique called NanoSeq to map genetic damage in healthy tissues from children who had received chemotherapy. The findings, published in Science, reveal that platinum-based chemotherapy drugs—a cornerstone of childhood cancer treatment—cause healthy cells to accumulate the same amount of DNA damage that would normally take a middle-aged adult decades to acquire. This premature aging may explain why childhood cancer survivors face elevated risks of secondary cancers, liver disease, and other health complications well into adulthood.
The researchers examined 186 tissue samples from nine children treated with platinum-based chemotherapy, including blood, liver tumors, and healthy liver tissue. They also analyzed samples from two children who received non-platinum drugs and 47 samples from children with non-liver cancers treated with various regimens. Control samples came from untreated children. The comparison was stark: healthy cells from children who had received platinum-based chemotherapy showed significantly higher numbers of DNA alterations across multiple tissue types. Some of these alterations are known to drive cancer development, though only a small fraction of survivors actually develop secondary malignancies.
The most striking discovery was a previously unknown pattern of DNA damage unique to the liver. This damage was not found in any other tissue type examined, suggesting that platinum-based drugs create tissue-specific genetic injuries. Researchers believe the damage occurs as the chemotherapy drugs break down in the liver—the organ responsible for metabolizing these medications—and that this localized injury may contribute to future liver disease in survivors. The finding challenges long-held assumptions in the field that the same chemotherapy would produce identical genetic damage across all tissues.
Wenger emphasized that chemotherapy remains essential for curing childhood cancers, and equally effective alternatives do not currently exist. The research does not argue for abandoning these drugs but rather for understanding them more deeply. By mapping exactly how platinum-based chemotherapy alters healthy cells, scientists now have a foundation for developing protective strategies—ways to shield the body from genetic damage while preserving the drugs' life-saving power against tumors. The goal is to make future cancer treatments safer, reducing the long-term health burden that survivors carry into adulthood.
Citations marquantes
Chemotherapy causes healthy cells in children to age genetically. In a relatively short period of time, it caused the same amount of DNA damage that would normally accumulate over decades.— Anna Wenger, Sahlgrenska Center for Cancer Research
By better understanding how treatment affects healthy tissues, we hope to develop new ways to protect the body against this DNA damage and make future cancer treatments even safer.— Anna Wenger
Envie de l'histoire complète ?
Lire l'original sur News-Medical ↗
Science & Space